Hypothalamitis and severe hypothalamic dysfunction associated with anti–programmed cell death ligand 1 antibody treatment

Autor: Tshuma, N., Glynn, N., Evanson, J., Powles, T., Drake, W.M.
Zdroj: In European Journal of Cancer November 2018 104:247-249
Databáze: ScienceDirect